Cargando…
Down-regulation of CXCL11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition
BACKGROUND: The poor prognosis of colorectal cancer (CRC) largely results from local invasion and tumor metastases. Epithelial-mesenchymal transition (EMT) is a key step in the progression of solid tumors and plays a vital role in tumor metastasis. Recent studies demonstrate that C-X-C motif chemoki...
Autores principales: | Gao, Yu Jie, Liu, De Lin, Li, Sheng, Yuan, Gao Feng, Li, Li, Zhu, Hong Yan, Cao, Guan Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205823/ https://www.ncbi.nlm.nih.gov/pubmed/30425523 http://dx.doi.org/10.2147/OTT.S167872 |
Ejemplares similares
-
CXCL16/ERK1/2 pathway regulates human podocytes growth, migration, apoptosis and epithelial mesenchymal transition
por: Chen, Yuan, et al.
Publicado: (2022) -
The ceRNA network regulates epithelial-mesenchymal transition in colorectal cancer
por: Li, Ruina, et al.
Publicado: (2023) -
MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition
por: Peng, Man, et al.
Publicado: (2017) -
MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Li, Jiazhi, et al.
Publicado: (2018) -
CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils
por: Mao, Zheying, et al.
Publicado: (2020)